Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MannKind
MannKind
Will Insulin Pricing Be MannKind Corporation's Downfall?
Motley Fool
Wed, 11/26/14 - 12:11 pm
MannKind
diabetes
insulin
inhaled insulin
Afrezza
drug pricing
MannKind’s Afrezza Remains in Sanofi’s Plans, RBC Says
Barron's
Fri, 11/21/14 - 03:07 pm
MannKind
inhaled insulin
Afrezza
diabetes
Sanofi
Is this MannKind Corporation's Worst Nightmare?
Motley Fool
Mon, 11/10/14 - 09:46 am
MannKind
Afrezza
diabetes
reimbursement
MannKind: What To Expect From Earnings
Seeking Alpha
Wed, 10/29/14 - 11:24 am
MannKind
earnings
Could MannKind Corporation Be Running Out of Money?
NASDAQ.com
Tue, 10/28/14 - 09:43 am
MannKind
MannKind Corporation's Investors Shouldn't Dance Around This Issue
Motley Fool
Tue, 10/21/14 - 09:18 am
MannKind
Dance Biopharm
MannKind: 5 Potential Technosphere Applications
Seeking Alpha
Sat, 10/18/14 - 10:49 am
MannKind
Technosphere
Why Is Sanofi Betting on MannKind Corporation's Afrezza?
Motley Fool
Mon, 10/6/14 - 10:57 am
Sanofi
MannKind
diabetes
Afrezza
MannKind Receives $150 Million Upfront Payment from Sanofi
Yahoo/Zacks.com
Fri, 10/3/14 - 04:28 pm
MannKind
Sanofi
Afrezza
MannKind and Sanofi Complete Afrezza Collaboration Deal
Yahoo/Zacks
Sat, 09/27/14 - 10:11 am
MannKind
Sanofi
Afrezza
diabetes
type 2 diabetes
Sanofi, MannKind say cutting insulin costs will make Afrezza more competitive
Fierce Pharma Marketing
Wed, 09/17/14 - 05:47 pm
Sanofi
MannKind
insulin
diabetes
Afrezza
What the Market is Telling MannKind
24/7 Wall St
Wed, 08/13/14 - 10:20 am
MannKind
Afrezza
insulin
inhaled insulin
Sanofi
Did MannKind Find Right Afrezza Partner in Sanofi?
Barron's
Tue, 08/12/14 - 05:31 pm
MannKind
Afrezza
Sanofi
diabetes
inhaled insulin
insulin
Most Popular News Headlines For Monday, August 11 2014
CP Wire
Tue, 08/12/14 - 09:13 am
Celltrion
Remsima
Jannsen
Remicade
Invokamet
JNJ
Sanofi
Cologuard
MannKind
Afrezza
EXACT Sciences
Most popular news headlines for Monday, August 11 2014
Tue, 08/12/14 - 09:07 am
Celltrion
Remsima
Jannsen
Remicade
Invokamet
JNJ
Sanofi
Cologuard
MannKind
Afrezza
EXACT Sciences
Sanofi fills some big shoes in $925M Afrezza pact with MannKind
Fierce Biotech
Mon, 08/11/14 - 08:48 am
Sanofi
MannKind
insulin
Afrezza
inhaled insulin
diabetes
Sanofi bets on inhaled insulin with up to $925 mln MannKind deal
Yahoo/Reuters
Mon, 08/11/14 - 07:59 am
MannKind
Sanofi
diabetes
inhaled insulin
Afrezza
insulin
MannKind: Why The Short Argument Is Shortsighted
Seeking Alpha
Sat, 07/26/14 - 09:54 am
MannKind
Afrezza
MannKind Pharma Gets Hedge Fund Treatment, Traders Rally Defence
Yahoo/StockTwits
Sat, 07/26/14 - 09:53 am
MannKind
Afrezza
MannKind Afrezza Partnership News Coming Within Weeks
The Street
Sat, 07/26/14 - 09:50 am
Afrezza
MannKind
diabetes
inhaled insulin
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »